ClassID:

92828

C07C235/20 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Recent Application in this class:
#1
20260085074
2026-03-26

COMPOSITIONS AND METHODS FOR TREATING CANCER

#2
20260055047
2026-02-26

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

#3
20250101036
2025-03-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

#4
20250092061
2025-03-20

COMPOSITIONS AND METHODS FOR TREATING CANCER

#5
20250074868
2025-03-06

POLYHYDROXYLATED PHOTOINITIATORS

#6
20240425437
2024-12-26

DERIVATIVES OF SOBETIROME

#7
20240317832
2024-09-26

UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE

#8
20240287018
2024-08-29

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

#9
20240287003
2024-08-29

ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION

#10
20240254075
2024-08-01

FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS

#11
20240116856
2024-04-11

NOVEL CAPSAICIN ANALOGS AND USES THEREOF

#12
20240109834
2024-04-04

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

#13
20240067656
2024-02-29

Compositions and methods for treating cancer

#14
20240010602
2024-01-11

PHENYL UNSATURATED KETONES AS HUMAN FACTOR XIIIA INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC DISEASES

#15
20230348364
2023-11-02

ISOTOPIC THYROMIMETIC COMPOUNDS

#16
20230331691
2023-10-19

Treprostinil derivative compounds and methods of using same

#17
20230242548
2023-08-03

Compositions and methods for treating cancer

#18
20230242473
2023-08-03

THYROMIMETICS

#19
20230135350
2023-05-04

Compositions and methods for treating cancer

#20
20230117425
2023-04-20

Immunomodulator compounds

#21
20230112086
2023-04-13

Photo-cleavable primer compositions and methods of use

#22
20230103027
2023-03-30

Surface primer compositions and methods of use

#23
20220112173
2022-04-14

Treprostinil derivative compounds and methods of using same

#24
20210276940
2021-09-09

Prostacyclin compounds, compositions and methods of use thereof

#25
20210253528
2021-08-19

CHEMICAL COMPOUNDS

#26
20210230183
2021-07-29

Compositions and methods for treating cancer

#27
20210052514
2021-02-25

Immunomodulator compounds

#28
20200407336
2020-12-31

Treprostinil derivative compounds and methods of using same

#29
20200347248
2020-11-05

Photo-cleavable primer compositions and methods of use

#30
20200347247
2020-11-05

Surface primer compositions and methods of use

#31
20200325092
2020-10-15

Derivatives of sobetirome

#32
20200255446
2020-08-13

Compositions and methods for treating cancer

#33
20200231538
2020-07-23

Compounds and therapeutics uses thereof

#34
20200181067
2020-06-11

FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS

#35
20200079724
2020-03-12

Prostacyclin compounds, compositions and methods of use thereof

#36
20200062726
2020-02-27

Treprostinil derivative compounds and methods of using same

#37
20190375704
2019-12-12

Modulators of the eIF2alpha pathway

#38
20190292163
2019-09-26

Treprostinil derivative compounds and methods of using same

#39
20190292153
2019-09-26

Acetophenone compound, preparation method thereof, and application thereof in fatty liver prevention and treatment

#40
20190263762
2019-08-29

Processes and intermediates for making sweet taste enhancers

#41
20190240171
2019-08-08

Preventive and therapeutic approach for aberrant cell differentiation and ISR-associated diseases

#42
20190210950
2019-07-11

Derivatives of sobetirome

#43
20190119295
2019-04-25

COMPOSITIONS AND METHODS FOR TREATING CANCER

#44
20180370931
2018-12-27

Processes and intermediates for making sweet taste enhancers

#45
20180334425
2018-11-22

Fluorinated amide derivatives and their uses as therapeutic agents

#46
20180289704
2018-10-11

Compounds useful as modulators of TRPM8

#47
20180194718
2018-07-12

Neprilysin inhibitors

#48
20180162829
2018-06-14

Treprostinil derivative compounds and methods of using same

#49
20180086730
2018-03-29

Treprostinil derivative compounds and methods of using same

#50
20180008554
2018-01-11

Immunomodulator compounds

#51
20170342020
2017-11-30

Modulators of the eIF2alpha pathway

#52
20170327479
2017-11-16

Processes and intermediates for making sweet taste enhancers

#53
20170327459
2017-11-16

Neprilysin inhibitors

#54
20170217999
2017-08-03

Surface primer compositions and methods of use

#55
20170217997
2017-08-03

Photo-cleavable primer compositions and methods of use

#56
20170114116
2017-04-27

Double-acylated GLP-1 compounds

#57
20170081303
2017-03-23

Treprostinil derivative compounds and methods of using same

#58
20170067874
2017-03-09

Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same

#59
20170015619
2017-01-19

Neprilysin inhibitors

#60
20160368930
2016-12-22

Compositions and methods for treating cancer

#61
20160368889
2016-12-22

Treprostinil derivative compounds and methods of using same

#62
20160317532
2016-11-03

Compounds useful as modulators of TRPM8

#63
20160289200
2016-10-06

Processes and intermediates for making sweet taste enhancers

#64
20160256425
2016-09-08

Prostacyclin compounds, compositions and methods of use thereof

#65
20160199330
2016-07-14

Aniline derivatives, their preparation and their therapeutic application

#66
20160193215
2016-07-07

Compounds as HIF-1α inhibitors and manufacturing process thereof

#67
20160137592
2016-05-19

Compounds advantageous in the treatment of central nervous system diseases and disorders

#68
20160130216
2016-05-12

Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof

#69
20160096800
2016-04-07

Modulators of the eIF2alpha pathway

#70
20150376128
2015-12-31

Neprilysin inhibitors

#71
20150191439
2015-07-09

Inhibitors targeting drug-resistant influenza A

#72
20150175529
2015-06-25

Prostacyclin compounds, compositions and methods of use thereof

#73
20150166503
2015-06-18

Treprostinil derivative compounds and methods of using same

#74
20150157733
2015-06-11

Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides

#75
20150148414
2015-05-28

Prostacyclin compounds, compositions and methods of use thereof

#76
20150147273
2015-05-28

RADIOLABELED ANALOG(S) OF COMPOUND 0118 AND USE THEREOF IN CONNECTION WITH PET AND/OR SPECT IMAGING TO DETERMINE WHETHER A PHARMACEUTICAL CONTAINING COMPOUND 0118 IS A CANDIDATE CANCER TREATMENT FOR A PATIENT

#77
20150119572
2015-04-30

Process for manufacturing aryloxyacetamides

#78
20140350019
2014-11-27

Aniline derivatives, their preparation and their therapeutic application

#79
20140336235
2014-11-13

Substituted biaryl alkyl amides

#80
20140256730
2014-09-11

Treprostinil derivative compounds and methods of using same

#81
20140228357
2014-08-14

Compounds as HIF-1alphainhibitors and manufacturing process thereof

#82
20140221330
2014-08-07

NDM inhibitor

#83
20140219995
2014-08-07

INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM

#84
20140128463
2014-05-08

Amide compound, preparation method and uses thereof

#85
20140107370
2014-04-17

Processes and intermediates for making sweet taste enhancers

#86
20140093513
2014-04-03

METHODS OF LOWERING PROPROTEIN CONVERSATE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#87
20140031363
2014-01-30

NMDA receptor antagonists for neuroprotection

#88
20130324557
2013-12-05

Compounds useful as modulators of TRPM8

#89
20130289118
2013-10-31

Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

#90
20130261132
2013-10-03

CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS

#91
20130035394
2013-02-07

Calixarene-based peptide conformation mimetics, methods of use, and methods of making

#92
20130005984
2013-01-03

11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent

#93
20120322878
2012-12-20

Polycationic compounds and uses thereof

#94
20120322761
2012-12-20

Heterocyclic CETP inhibitors

#95
20120309801
2012-12-06

Calixarene-based peptide conformation mimetics, methods of use, and methods of making

#96
20120232120
2012-09-13

AMINO ACID AMIDES OF PHENOXYBUTYRIC ACID DERIVATIVES

#97
20120220577
2012-08-30

GLYCINE B ANTAGONISTS

#98
20120071457
2012-03-22

Metallo-β-lactamase inhibitors

#99
20120035196
2012-02-09

CARBOXYLIC ACID COMPOUND

#100
20120022054
2012-01-26

NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS

#101
20110319490
2011-12-29

Methods and compositions for the treatment of irritable bowel syndrome

#102
20110312965
2011-12-22

Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties

#103
20110312875
2011-12-22

Peptidic compounds

#104
20110245494
2011-10-06

Processes and intermediates for making sweet taste enhancers

#105
20110207605
2011-08-25

3-aminocarbonyl-substituted benzoylcyclohexanediones and their use as herbicides

#106
20110178092
2011-07-21

HIV-1 Protease Inhibitors

#107
20110124664
2011-05-26

Polycationic compounds and uses thereof

#108
20110098352
2011-04-28

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

#109
20110082210
2011-04-07

FATTY ACID FIBRATE DERIVATIVES AND THEIR USES

#110
20110046138
2011-02-24

Compounds advantageous in the treatment of central nervous system diseases and disorders

#111
20110039714
2011-02-17

Probes, Systems, and Methods for Drug Discovery

#112
20110028562
2011-02-03

Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use

#113
20100331410
2010-12-30

Biaryl Amides

#114
20100324130
2010-12-23

DAA PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR CANCER IMAGING AND TREATMENT

#115
20100298344
2010-11-25

Polycationic compounds and uses thereof

#116
20100267669
2010-10-21

Heterocyclic CETP inhibitors

#117
20100261772
2010-10-14

Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

#118
20100144532
2010-06-10

Process for manufacture of high purity D-(−)--diethyl-2-(α-naphthoxy) propionamide

#119
20100087543
2010-04-08

Pharmaceutical use of substituted amides

#120
20100063298
2010-03-11

11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent

#121
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#122
20090312286
2009-12-17

DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORS

#123
20090275714
2009-11-05

Ruthenium complexes as catalysts for metathesis reactions

#124
20090270423
2009-10-29

Antibacterial small molecules and methods for their synthesis

#125
20090258884
2009-10-15

Substituted amides

#126
20090253787
2009-10-08

Short-acting sedative hypnotic agents for anesthesia and sedation

#127
20090253710
2009-10-08

NMDA receptor antagonists for neuroprotection

#128
20090242822
2009-10-01

Perfluoroalkyl substituted phenol derivatives as surface modifiers

#129
20090239811
2009-09-24

Polycationic compounds and uses thereof

#130
20090118169
2009-05-07

NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF

#131
20090043129
2009-02-12

POTENT AND SELECTIVE LIGANDS OF CANNABINOID RECEPTORS

#132
20090023926
2009-01-22

Trityl Derivatives for Enhancing Mass Spectrometry

#133
20080306084
2008-12-11

Substituted amide compounds

#134
20080300287
2008-12-04

Peptidic compounds

#135
20080300164
2008-12-04

Calixarene-based peptide conformation mimetics, methods of use, and methods of making

#136
20080234199
2008-09-25

Chemical Compounds

#137
20080171692
2008-07-17

Substituted pyridyoxy amides

#138
20080167360
2008-07-10

Cycloalkylidene compounds as selective estrogen receptor modulators

#139
20080114064
2008-05-15

Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid

#140
20080090825
2008-04-17

Metallo-β-lactamase inhibitors

#141
20070244198
2007-10-18

Carboxylic Derivatives

#142
20070213316
2007-09-13

N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives

#143
20070142381
2007-06-21

Calcium receptor modulating agents

#144
20070135631
2007-06-14

Heterocyclic CETP inhibitors

#145
20070092467
2007-04-26

Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers

#146
20070066683
2007-03-22

Selective peroxisome proliferator activated receptor modulators

#147
20070021473
2007-01-25

Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof

#148
20060258866
2006-11-16

Carboxylic derivates

#149
20060247264
2006-11-02

Modulators of the glucocorticoid receptor

#150
20060240988
2006-10-26

Fungicides

#151
20060235050
2006-10-19

Diamine calcium channel blockers

#152
20060217346
2006-09-28

Fungicides

#153
20060194879
2006-08-31

Pharmaceutically useful salts of carboxylic acid derivates

#154
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#155
20060194763
2006-08-31

N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides

#156
20060179497
2006-08-10

Methods to treat conditions associated with insulin signaling dysregulation

#157
20060166990
2006-07-27

Aminobenzophenone compounds

#158
20060166296
2006-07-27

Standard compound for immunoassay for dioxin and method of immunoassay for dioxin

#159
20060142392
2006-06-29

Process for preparing (2s)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid derivatives

#160
20060142389
2006-06-29

Pharmaceutically useful salts of carboxylic acid derivatives

#161
20060116424
2006-06-01

Short-acting sedative hypnotic agents for anesthesia and sedation

#162
20060111587
2006-05-25

Aromatic compounds

#163
20060111406
2006-05-25

Amide linker peroxisome proliferator activated receptor modulators

#164
20060041024
2006-02-23

Polycationic compounds and uses thereof

#165
20060025474
2006-02-02

Bisphenyl compounds useful as vitamin D3 receptor agonists

#166
20050288367
2005-12-29

Benzyloxy derivatives as MAOB inhibitors

#167
20050282822
2005-12-22

Therapeutic agents

#168
20050234061
2005-10-20

Substituted amides

#169
20050222261
2005-10-06

Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance

#170
20050171204
2005-08-04

Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α (PPAR)

#171
20050148656
2005-07-07

Carboxylic derivates

#172
20050143426
2005-06-30

Calcium receptor modulating agents

#173
20050131068
2005-06-16

Therapeutic agents

#174
20050113364
2005-05-26

Short-acting sedative hypnotic agents for anesthesia and sedation

#175
20050113362
2005-05-26

Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR)

#176
20050090546
2005-04-28

Aspartic protease inhibitors

#177
20050009921
2005-01-13

Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same